양재석 (연세대학교 의과대학, 세브란스병원)님 | 한빛사연구자 > 한빛사

연세대학교 의과대학, 세브란스병원

최종업데이트 2025.01.24.

Genetic Landscape of Kidney Failure in a Korean Transplant Cohort: Genome-Wide Association and Multi-Polygenic Risk Score Analyses
- J. Am. Soc. Nephrol., Jun 17 2026, | https://doi.org/10.1681/ASN.0000001168
- 2026-06
- 의약학
- 한빛사논문
Selective depletion of ABO-responsive B cells by T-cell-engaging bispecific antibody conjugates for ABOi transplantation
- Blood, Apr 23 2026, 147 (17) | https://doi.org/10.1182/blood.2025030660
- 2026-04
- 의약학
- 한빛사논문
Synthetic Bilirubin-Based Nanomedicine Protects Against Renal Ischemia/Reperfusion Injury Through Antioxidant and Immune-Modulating Activity
- Adv. Healthc. Mater., Jan 23 2025, | https://doi.org/10.1002/adhm.202403846
- 2025-01
- 의약학
- 한빛사논문
Interleukin-2/anti-interleukin-2 immune complex attenuates cold ischemia-reperfusion injury after kidney transplantation by increasing renal regulatory T cells
- Clin. Transl. Med., Mar 2024, 14 (3) | https://doi.org/10.1002/ctm2.1631
- 2024-03
- 의약학
- 한빛사논문
Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways
- Kidney Int., 2023 Jul;104(1):163-180 | https://doi.org/10.1016/j.kint.2023.03.030
- 2023-07
- 생명과학
- 한빛사논문

연구자 ID

저자논문